Interferon gamma (IFN-γ) negative CD4+ and CD8+ T-cells can produce immune mediators in response to viral antigens.


Journal

Vaccine
ISSN: 1873-2518
Titre abrégé: Vaccine
Pays: Netherlands
ID NLM: 8406899

Informations de publication

Date de publication:
03 01 2019
Historique:
received: 27 03 2018
revised: 06 11 2018
accepted: 12 11 2018
pubmed: 22 11 2018
medline: 7 6 2019
entrez: 22 11 2018
Statut: ppublish

Résumé

Evaluation of antigen-specific T-cell responses to viral antigens is frequently performed on IFN-γ secreting cells. However, T-cells are capable of producing many more functions than just IFN-γ, some of which, like Perforin, are associated with immune protection in HIV-1 disease elite controllers. We evaluated the extent of missed T-cell functions when IFN-γ secretion is used as a surrogate marker for further evaluation of T-cell functions. Intracellular cytokine staining assay and flow cytometry were used to assess peripheral blood mononuclear cells (PBMCs) from 31 HIV-infected ART-naive individuals for the extent to which gated CD4+ and CD8+ IFN-γ producing and non-producing T-cells also secreted IL-2, Perforin, and TNF-α functions. Similarly, the extent of missed virus-specific responses in IFN-γ ELISpot assay negative T-cells from 5 HIV-1 uninfected individuals was evaluated. Cells from HIV-infected individuals were stimulated with pooled consensus group M (Con M) peptides; and those from healthy individuals were stimulated with pooled adenovirus (Ad) peptides. Overall, frequencies of virus-specific IFN-γ secreting CD4+ and CD8+ cells were low. Proportions of IFN-γ negative CD4+ expressing IL-2, Perforin, or TNF-α to Con M were significantly higher (5 of 7 functional profiles) than the corresponding IFN-γ positive CD4+ (0 of 7) T-cell phenotype, p = 0.02; Fisher's Exact test. Likewise, proportions of CD8+ T-cells expressing other functions were significantly higher in 4 of the 7 IFN-γ negative CD8+ T-cells. Notably, newly stimulated Perforin, identified as Perforin co-expression with IL-2 or TNF-α, was significantly higher in IFN-γ negative CD8+ T-cell than in the positive CD8+ T-cells. Using SEB, lower responses in IFN-γ positive cells were most associated with CD4+ than CD8+ T-cells. These findings suggest that studies evaluating immunogenicity in response to HIV and Adenovirus viral antigens should not only evaluate T-cell responsiveness among IFN-γ producing cells but also among those T-cells that do not express IFN-γ.

Identifiants

pubmed: 30459072
pii: S0264-410X(18)31547-0
doi: 10.1016/j.vaccine.2018.11.024
pmc: PMC6290111
pii:
doi:

Substances chimiques

Antigens, Viral 0
Immunologic Factors 0
Interleukin-2 0
Peptides 0
Tumor Necrosis Factor-alpha 0
Perforin 126465-35-8
Interferon-gamma 82115-62-6

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

113-122

Subventions

Organisme : Medical Research Council
ID : MC_U950097145
Pays : United Kingdom
Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UU_00027/1
Pays : United Kingdom
Organisme : NIMH NIH HHS
ID : R25 MH064712
Pays : United States
Organisme : NIMH NIH HHS
ID : R25 MH123256
Pays : United States

Informations de copyright

Copyright © 2018 The Authors. Published by Elsevier Ltd.. All rights reserved.

Références

Cytometry A. 2011 Feb;79(2):167-74
pubmed: 21265010
Nature. 2001 Mar 1;410(6824):106-11
pubmed: 11242051
BioDrugs. 1998 Sep;10(3):215-25
pubmed: 18020597
Eur J Immunol. 2008 Feb;38(2):350-63
pubmed: 18200635
Proc Natl Acad Sci U S A. 2000 Dec 5;97(25):13812-7
pubmed: 11095721
PLoS Med. 2006 Oct;3(10):e403
pubmed: 17076553
J Virol. 2003 Jul;77(13):7330-40
pubmed: 12805431
Blood. 2000 Nov 1;96(9):3094-101
pubmed: 11049989
AIDS Res Hum Retroviruses. 2012 Apr;28(4):384-92
pubmed: 21867408
J Immunol Methods. 2007 Mar 30;320(1-2):18-29
pubmed: 17222422
Cytometry A. 2014 Nov;85(11):969-77
pubmed: 25044796
J Virol. 2011 Feb;85(3):1275-86
pubmed: 21084478
J Immunol. 2009 Apr 15;182(8):4751-61
pubmed: 19342652
AIDS Res Hum Retroviruses. 2016 Mar;32(3):237-46
pubmed: 26548707
J Virol. 2010 Apr;84(8):3868-78
pubmed: 20130059
J Clin Invest. 2011 Nov;121(11):4322-31
pubmed: 21965332
Nat Rev Immunol. 2008 Apr;8(4):247-58
pubmed: 18323851
J Exp Med. 1992 Sep 1;176(3):739-50
pubmed: 1512539
Vaccine. 2017 Apr 4;35(15):1898-1906
pubmed: 28285985
J Virol. 2014 Feb;88(3):1819-24
pubmed: 24227857
AIDS. 2013 Jan 2;27(1):17-27
pubmed: 23079801
PLoS Pathog. 2010 Mar 05;6(3):e1000798
pubmed: 20221423
Clin Exp Immunol. 1992 Oct;90(1):6-12
pubmed: 1395102
J Exp Med. 1999 Mar 15;189(6):991-8
pubmed: 10075982
Blood. 2002 Apr 1;99(7):2505-11
pubmed: 11895786
J Virol. 2010 May;84(10):4998-5006
pubmed: 20200250
J Exp Med. 2009 Jun 8;206(6):1253-72
pubmed: 19487423
Cells. 2012 May 10;1(2):111-26
pubmed: 24710418
AIDS. 2011 Mar 13;25(5):679-89
pubmed: 21297424
AIDS Res Hum Retroviruses. 2007 Jan;23(1):67-76
pubmed: 17263635
AIDS. 2005 Jul 22;19(11):1165-72
pubmed: 15990569
PLoS One. 2014 Aug 05;9(8):e104235
pubmed: 25093660
Lancet. 2008 Nov 29;372(9653):1881-1893
pubmed: 19012954
J Immunol. 2009 May 1;182(9):5560-9
pubmed: 19380804
PLoS Pathog. 2010 May 27;6(5):e1000917
pubmed: 20523897
Am J Trop Med Hyg. 2005 Jul;73(1):44-9
pubmed: 16014830
J Infect Dis. 2004 Nov 1;190(9):1692-6
pubmed: 15478077
Mol Cell Biol. 1995 May;15(5):2359-66
pubmed: 7739519
Proc Natl Acad Sci U S A. 2012 Jun 19;109(25):9983-8
pubmed: 22665800
J Virol. 2010 Oct;84(20):10522-32
pubmed: 20686035
Blood. 2006 Jun 15;107(12):4781-9
pubmed: 16467198
Vaccine. 2014 Jun 24;32(30):3787-95
pubmed: 24837770
J Virol. 2009 Aug;83(15):7641-8
pubmed: 19458000

Auteurs

Ritah Nakiboneka (R)

Medical Research Council/Uganda Virus Research Institute and London School of Hygiene and Tropical Medicine, Uganda Research Unit (MRC/UVRI & LSHTM Uganda Research Unit), Entebbe, Uganda.

Susan Mugaba (S)

Medical Research Council/Uganda Virus Research Institute and London School of Hygiene and Tropical Medicine, Uganda Research Unit (MRC/UVRI & LSHTM Uganda Research Unit), Entebbe, Uganda.

Betty O Auma (BO)

Medical Research Council/Uganda Virus Research Institute and London School of Hygiene and Tropical Medicine, Uganda Research Unit (MRC/UVRI & LSHTM Uganda Research Unit), Entebbe, Uganda.

Christopher Kintu (C)

Medical Research Council/Uganda Virus Research Institute and London School of Hygiene and Tropical Medicine, Uganda Research Unit (MRC/UVRI & LSHTM Uganda Research Unit), Entebbe, Uganda.

Christina Lindan (C)

Department of Epidemiology & Biostatistics, and Global Health Sciences, University of California, San Francisco (UCSF), United States.

Mary Bridget Nanteza (MB)

Medical Research Council/Uganda Virus Research Institute and London School of Hygiene and Tropical Medicine, Uganda Research Unit (MRC/UVRI & LSHTM Uganda Research Unit), Entebbe, Uganda.

Pontiano Kaleebu (P)

Medical Research Council/Uganda Virus Research Institute and London School of Hygiene and Tropical Medicine, Uganda Research Unit (MRC/UVRI & LSHTM Uganda Research Unit), Entebbe, Uganda.

Jennifer Serwanga (J)

Medical Research Council/Uganda Virus Research Institute and London School of Hygiene and Tropical Medicine, Uganda Research Unit (MRC/UVRI & LSHTM Uganda Research Unit), Entebbe, Uganda. Electronic address: Jennifer.Serwanga@mrcuganda.org.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH